Moreover presence of insulin resistance and diabetes are risk factors for fibrosis progression and nonresponse to antiviral therapy in chronic hepatitis C (CHC).

• 此外，胰岛素抵抗和糖尿病是慢性丙型肝炎（CHC）中纤维化进展以及对抗病毒治疗无应答的危险因素。